Pharma IQ will hold a conference next month on the use of oligonucleotides in drug development.
The event will include, among others, sessions on vector-derived RNAi as tools and therapeutics; gene silencing by the gymnotic delivery of oligos; microRNA silencing; and use of miRNAs as biomarkers.
Details about the conference can be found here.